Biomedical subjects

D Grunberger

Publications and source records attributed to D Grunberger.

At least 109 records · Page 6Linked to original sources

PubMed1977

Differential excision from DNA of the C-8 and N2 guanosine adducts of N-acetyl-2-aminofluorene by single strand-specific endonucleases.

Purified duck reticulocyte DNA was reacted in vitro with [9-14C]-N-acetoxy-N-acetyl-2-aminofluorene. Hydrolysis of the [14C]-N-acetyl-2-aminofluorene-modified DNA followed by Sephadex LH-20 column chromatography showed that 85% of the DNA-bound [14C]-N-acetyl-2-aminofluorene was N-(deoxyguanosin-8-yl)-N-acetyl-2-aminofluorene and 15% was 3-(deoxyguanosin-N2-yl)-N-acetyl-2-aminofluorene. When this modified DNA was incubated with the single strand-specific nuclease, S1, and the undigested fraction of the DNA was analyzed, there was preferential loss of the quanosine C-8 adduct from the DNA. Moreover, analysis of the nucleosides released by exposure of N-acetyl-2-aminofluorene-modified DNA to a single strand-specific nuclease from Neurospora crassa showed only the guanosine C-8 adduct in the supernatant fraction. These results suggest that, whereas the N-(deoxyguanosin-8-yl)-N-acetyl-2-aminofluorene adduct in DNA causes major conformational changes in the double-stranded helix and localized regions of denaturation, the 3-(deoxyguanosin-N2-yl)-N-acetyl-2-aminofluorene adduct does not cause major distortions of the native DNA structure.

2-Acetylaminofluorene↗

PubMed1976

Multiple sites of action of N-hydroxy-2-acetylaminofluorene rat hepatic nuclear transcription.

This study attempts to identify the site(s) of action of N-hydroxy-2-acetylaminofluorene (N-OH-AAF) in relation to its inhibition of rat hepatic nuclear RNA synthesis. Two hr after N-OH-AAF injection (3 mg/100 g body weight), rat hepatic nuclear synthesis and nucleolar RNA synthesis in vitro were inhibited by 60 and 80%, respectively. When total nuclear RNA polymerases were solubilized and assayed in the presence of alpha-amanitin (3.2 mug/ml), only alpha-amanitin-sensitive activity was reduced (50%) by N-OH-AAF. Diethylamino-ethyl-Sephadex column chromatography confirmed this finding and further demonstrated that RNA polymerase II was the activity selectively inhibited. Since N-OH-AAF dramatically inhibited nucleolar RNA synthesis but had little effect on RNA polymerase I activity, per se, we therefore concluded that, in addition to its direct inhibitory effect on the enzymic function of RNA polymerase II, N-OH-AAF must also cause impairment of the nucleolar DNA template function.

Amanitins↗

PubMed1975

Products obtained after in vitro reaction of 7,12-dimethylbenz[alpha]anthracene 5,6-oxide with nucleic acids.

Several lines of evidence suggest that oxide derivatives of carcinogenic polycyclic hydrocarbons are the reactive intermediates for in vivo binding to cellular nucleic acids. In the present study the covalent binding of 7,12-dimethylbenz[alpha]anthracene 5,6-oxide to synthetic homopolymers and nucleic acids in aqueous-acetone solutions has been investigated. Poly(G) was found to be the most reactive nucleic acid and underwent approximately 7-10% modification. Alkaline hydrolysis of the poly(G)-dimethylbenzathracene conjugate yielded chromatographically distinct polycyclic hydrocarbon-modified nucleotides which were further characterized by spectral analyses and enzymatic and chemical degradation. When the oxide was allowed to react with GMP or dGMP, at least two products were obtained in about 1% yield. Acid hydrolysis of the dGMP-dimethylbenzanthracene conjugates liberated the corresponding guanine-dimethylbenzathracene products. Mass spectral analysis of the modified bases provided direct evidence that we had obtained covalent binding of the poly-cyclic hydrocarbon to guanine. The mass spectral cleavage pattern suggest that one of these products is a hydroxydihydro derivative of dimethylbenzanthracene bound to guanine and the other is a dimethylbenzanthracene-guanine conjugate. Additional structural aspects of these guanine derivatives are discussed.

9,10-Dimethyl-1,2-benzanthracene↗

PubMed1975